Intranasal Drug Delivery: How, Why and What for?
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a target issue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. The present paper reviews the relevant aspects of nasal anatomy, physiology and histology, and refers to the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation in appropriate nasal pharmaceutical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is non-invasive, painless, non-stressful, and relatively easy to perform without requiring a medical specialist [246,247,248].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [248]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Research works printed but not linked: 5
- [27]27. Stevens A., Lowe J., Human histology, Mosby, Philadelphia, USA, 1997.
- [35]35. Dae-Duk Ki, Drug Absorption Studies: In situ, In vitro and In silico models, chapter 9, Springer, USA, 2007.
- [56]56. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv, 2006; 13:31-38.
- [72]72. Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus in infants and young children. J Infect Dis, 2004; 190:2096-2103.
- [113]113. Hussain A.A., Bawarshi-Nassar R., Huang C.H., Transnasal Systemic Medications. Elsevier, Amsterdam, 1985. 123.
Cited by
Items 501–600 of 661
Topalian, R., Kavallaris, L., Rosenau, F., & Mavoungou, C. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00643 · Cited by 3
Li, J., Guo, Y., Liu, Y., Gao, Q., Wang, S., Wu, L., Wang, C., Ren, X., & Zhang, J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17060788 · Cited by 3
Shi, J., Hong, L., Zhang, Y., Ye, C., Huang, X., Lu, Y., Liu, Y., Liu, J., Ao, D., Zhou, Y., et al. (2025) · MedComm · doi:10.1002/mco2.70301 · Cited by 4
Li, Z., Xu, H., Wang, S., Nie, Q., Jia, B., Su, J., Xu, G., Yang, R., Wang, Z., Zhang, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.018 · Cited by 3
Drug delivery strategies for paediatric diffuse midline gliomas.
Duca, S., Parvar, S. J., Kumeta, L., Bradshaw, T., Chan, W., de Cogan, F., Dziemidowicz, K., Gershkovich, P., Marlow, M., Morris, C., et al. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115695 · Cited by 3
Nose to Brain Delivery of Curcumin Loaded Therapeutic Nanostructures for Neurodegenerative Diseases
Kalita, R., Sarma, A., Baruah, H., Zaman, A., & Goswami, D. (2026) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.70021 · Cited by 3
Bénech, H., Flament, V., Lhotellier, C., Roucairol, C., & Joudinaud, T. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010080 · Cited by 3
Das, S. S., Kumar, A., Joshi, B., Alipour, S., & Dehshahri, A. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150797 · Cited by 3
Drug Delivery to the Brain via Focused Ultrasound
Arvanitis, C., & McDannold, N. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800870-6.00018-2 · Cited by 3
Hossain, M. T., Malakar, A., Yeasin, M., O’Connell, W., Akash, M. M. H., Borojeni, A. A. T., Samanta, D., Williams, G., Reineke, J., Farias, G., et al. (2025) · Frontiers in Drug Delivery · doi:10.3389/fddev.2025.1721960 · Cited by 3
Patil, S. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00012-6 · Cited by 3
Drug Delivery and Safety Considerations
Johnson, J. G., & Chinnadurai, S. K. (2021) · Veterinary Clinics of North America Exotic Animal Practice · doi:10.1016/j.cvex.2021.08.014 · Cited by 3
New Insights into Nanoparticulate Carriers for Direct Nose‐to‐Brain Drug Delivery
Pardeshi, C. V., Handa, M., & Shukla, R. (2021) · Wiley eBooks · doi:10.1002/9783527832095.ch9 · Cited by 4
Nose to Brain Drug Delivery System
Patil, G. D., Nikam, A. R., Patil, P. A., & Sonar, A. D. (2021) · Research Journal of Pharmaceutical Dosage Forms and Technology · doi:10.52711/0975-4377.2021.00054 · Cited by 3
Modaresi, M. A., Heidarinejad, G., Maddahian, R., & Firoozabadi, B. (2022) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2022.106120 · Cited by 3
Malyshev, A. V., Pavshintsev, V. V., Mitkin, N. A., Sukhanova, I. A., Gedzun, V. R., Zlobin, A. S., Doronin, I. I., Babkin, G. A., & Sawyer, T. K. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1333258 · Cited by 3
DRUG DELIVERY AND ITS DEVELOPMENTS FOR PULMONARY SYSTEM
Sunitha, R., Prabha, K. S., & Prasanna, P. M. (2011) · Cited by 3
Importancia de la vía nasal para la administración de opioides
Paredes-Mogollo, A. (2015) · Medicina Paliativa · doi:10.1016/s1134-248x(15)30007-0 · Cited by 3
Nanomedicines for Nasal Drug Delivery
Bali, V., Singh, S., & Kumar, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-29265-1_8 · Cited by 4
Marketing research on intranasal medicines of domestic market
Бурлака, Б. С., Червоненко, Н. М., & Belenichev, I. F. (2016) · Current issues in pharmacy and medicine science and practice · doi:10.14739/2409-2932.2016.3.78001 · Cited by 3
O’Doherty, J., Mangini, C. D., Hamby, D. M., Boozer, D., Singh, N., & Hippeläinen, E. T. (2020) · Medical Physics · doi:10.1002/mp.14669 · Cited by 3
A Promising Drug Delivery: Intranasal Drug Delivery System
Sharma, J. (2021) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2021.v69i01.022 · Cited by 3
Hong, S., Lin, C., Hu, J., Piao, J., & Piao, M. G. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00634 · Cited by 2
Routes of administration for the non-human primate
Harvey, W. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-813088-9.00004-5 · Cited by 2
de Grunt, M. N., Jong, B. D., Hollmann, M. W., Ridderikhof, M. L., & Weenink, R. P. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13092560 · Cited by 2
Mieda, S., Inoue, K., Ito, A., Yada, S., Miyajima, M., & Fukami, T. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106454 · Cited by 2
Nanonizing bioactives: precision chemistry for next-gen therapeutics
Biswas, P., Desai, B. M. A., Ghosh, S., Banerjee, B., Verma, D., Kathirselvam, M., Chauhan, S., & Gupta, P. (2026) · Discover Materials · doi:10.1007/s43939-026-00542-5 · Cited by 2
Martini, L., Valori, C. F., Morrone, M., Brambilla, L., & Rossi, D. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18040484 · Cited by 2
An, J., Li, X., Li, Z., Wang, J., & Pan, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04417-y · Cited by 5
NANOEMULSIONS – PRESENT AND FUTURE PERSPECTIVE - AN OVERVIEW
Khanna, V., Singh, S., Baghel, D. S., Kaur, B., Nayar, A., & Ghimire, R. (2018) · Journal of Emerging Technologies and Innovative Research · Cited by 3
Veselov, V. V., Николаевич, Е. Н., Trukhan, V. M., Zvyagin, A. V., & Nosyrev, A. E. (2023) · Pharmaceutical Chemistry Journal · doi:10.1007/s11094-023-02845-w · Cited by 3
Al-Khalasi, U. S. S., Al-Alawi, A. K. A., Al-Jufaili, M., Al-Reesi, A., Al-Zakwani, I. S., Al-Asmi, M. S. R., Al-Riyami, F. B., & Vishwakarma, R. K. (2023) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2023.10.009 · Cited by 2
Modaresi, M. A., & Shirani, E. (2024) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2024.114463 · Cited by 2
Baranauskaitė, J., Aydin, M., Üner, B., & Taş, Ç. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02791-0 · Cited by 3
RetractedSerralheiro, A., Alves, G., & Falcão, A. C. (2012) · Open Chemistry · doi:10.2478/s11532-012-0021-6 · Cited by 2
Self-citationFORMULATION AND EVALUATION OF MICROSPHERES FOR NASAL DELIVERY OF ANTI-HYPERTENSIVE DRUG
Shelake, S. S., Mhetre, R. M., Patil, S., Patil, S. S., & Khade, V. L. (2016) · INDIAN DRUGS · doi:10.53879/id.53.10.10388 · Cited by 2
ENHANCED BIOAVAILABILITY OF DRUGS VIA INTRANASAL DRUG DELIVEY SYSTEM
Ali, A., Prajapati, S. K., Devendra, S., & Kausar, S. (2012) · International Research Journal of Pharmacy · Cited by 2
Sullivan, T. (2011) · Cited by 2
Intranasal midazolam administration enhances amnesic effect in rats
Kadono, T., Kawano, T., Yamanaka, D., Tateiwa, H., Urakawa, M., Locatelli, F. M., & Yokoyama, M. (2016) · Journal of Anesthesia · doi:10.1007/s00540-016-2153-x · Cited by 2
Nanoemulsions as delivery vehicles for food and pharmaceuticals
Kaur, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804306-6.00018-0 · Cited by 4
Healthcare Applications of Nanoemulsions
Malik, S., Kishore, S., Kumari, S. A., & Kumari, A. (2021) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-7998-8378-4.ch023 · Cited by 2
Wei, Y., Chen, I.-Y., TAMOGI, H., Sugita, C., Daimaruya, N., Hirokawa, T., Kato, K., ITAMI, T., Sano, T., & YAMASHITA, K. (2023) · Journal of Veterinary Medical Science · doi:10.1292/jvms.22-0484 · Cited by 2
Enhancement of intranasal mucosal immunization of mucosal vaccines by ultrasonic treatment
Xu, H., Liao, Y., Svetlana, M., Yang, D., Wan, H., & Liu, Z. (2023) · Bio-Design and Manufacturing · doi:10.1007/s42242-023-00231-9 · Cited by 2
Formulation Strategies for Nose-to-Brain Drug Delivery
Vohra, M., Amir, M., Sharma, A., & Wadhwa, S. (2022) · Journal of Pharmaceutical Technology Research and Management · doi:10.15415/jptrm.2022.101008 · Cited by 2
Luciani-Giacobbe, L. C., Sanchez, M. F., & Olivera, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-84860-6_102 · Cited by 2
Development of nanocarriers for the encapsulation of cannabinoids and other bioactive compounds
Δεμισλή, Σ. (2023) · doi:10.12681/eadd/54013 · Cited by 2
Sonvico, F., Bazzo, G. C., & Stulzer, H. K. (2025) · Neuromethods · doi:10.1007/978-1-0716-4474-4_9 · Cited by 1
Harnessing Liposomes for Advanced Gene Therapy: A Comprehensive Review
Vemuri, S. P., Karnati, P., Vadayar, K. P., & Singh, P. (2025) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0050 · Cited by 3
Ezzi, S., Salamatullah, H. K., Alzahrani, D., Alshrif, A., Faidah, D. E., Baljoon, J. M., Hakami, A. Y., & Babkair, K. A. (2025) · Seizure · doi:10.1016/j.seizure.2025.08.013 · Cited by 1
Evaluating the Efficacy of Intranasal Sedation in the Dental Setting: A Scoping Review
Almutawwif, M., Gogandi, H., Faqiri, F., Aloufi, A., Bamunif, M., Hazzazi, A., & Abed, H. (2025) · Special Care in Dentistry · doi:10.1111/scd.70089 · Cited by 1
Intranasal Drug Delivery: Exploiting Nasal Anatomy for Enhanced Therapeutic Outcomes
Kumar, A., Rajpoot, K., & Jain, S. K. (2025) · Current Pharmaceutical Design · doi:10.2174/0113816128392902250916114510 · Cited by 1
Studying nasal aerosols in microfluidics: opportunities and challenges
Gholizadeh, H., & Cheng, S. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2579172 · Cited by 1
Ličen, A., Grmaš, J., Gubič, Š., Trontelj, J., Gomboc, T., Hriberšek, M., & Harih, G. (2026) · Biomedicines · doi:10.3390/biomedicines14020329 · Cited by 1
Bradbury, S., Dickson, B., Curtis, N. J., Bunton, D. C., Goncalves, K., & Przyborski, S. A. (2026) · Journal of Anatomy · doi:10.1111/joa.70130 · Cited by 1
Upadhyay, R., Jain, A., Trivedi, K., & Desavathu, M. (2026) · Journal of drug targeting · doi:10.1080/1061186x.2026.2659210 · Cited by 1
Strategies to Improve Sensitivity to Radiotherapy in Pediatric Solid Tumors
Shaikh, M. G., Brown, M. L., Aye, J. M., & Beierle, E. A. (2026) · Cancers · doi:10.3390/cancers18132103 · Cited by 1
Intranasal dopamine: Anatomical pathways, biological mechanisms and neuromodulatory potential
Chao, O. Y.-H., Nikolaus, S., Mattern, C., Chiou, L., & Huston, J. P. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106866 · Cited by 1
Nanomaterials in Drug Delivery System
Razali, N. I. M., Saufi, N. S. M., Raus, R. A., Nawawi, W. M. F. W., & Basri, D. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-99602-8_11 · Cited by 1
Development of an MRI-Compatible Nasal Drug Delivery Method for Probing Nicotine Addiction Dynamics
Mujica-Parodi, L. R., Kumar, R., Wenke, M. R., Amgalan, A., Lithen, A., Govindarajan, S. T., Makaryus, R., Benveniste, H., & Strey, H. H. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122069 · Cited by 1
Goetz, K., Sun, Y., Féchir, K., Kretzschmar, E., & Buettel, I. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9524-6_25 · Cited by 1
Complete Review on Nasal Drug Delivery Systems
Kumari, N., Kalyanwat, R., & Singh, V. K. (2013) · Cited by 2
Intranasal Medication Delivery in Children for Brain Disorders
Zhang, G., McCrary, M. R., & Wei, L. (2019) · Springer series in translational stroke research · doi:10.1007/978-3-030-16715-8_11 · Cited by 1
Potential therapeutic road for targeting the SARS-CoV-2 at throat
Kaya, M., Abuaisha, A. M., Serakıncı, N., & Öztürk, S. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_035 · Cited by 1
Application of Nanoemulsions in Breast Cancer Treatment
Nirmala, M. J., Shiny, P. J., Dhas, S. P., Kizhuveetil, U., Raj, U. S., & Nagarajan, R. (2021) · Advances in chemical and materials engineering book series · doi:10.4018/978-1-7998-8378-4.ch013 · Cited by 1
Nose-to-Brain Targeted Drug Delivery Bypassing the Blood-Brain Barrier: An Overview
Pandey, M. (2022) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-7998-8908-3.ch007 · Cited by 1
Novel Cellular Stress Models with Implications in Understanding and Treating ENT Pathologies
Panda, N. K., Sharma, M., Ramavat, A. S., Patro, S. K., Nayak, G. R., & Kaushal, K. (2022) · Springer eBooks · doi:10.1007/978-981-16-8845-4_7 · Cited by 2
Nanomaterials in nose-to-brain delivery
Jain, H., Dalvi, H., Bhat, A., Agrawal, A., Madan, J., Singh, P. K., Mehra, N. K., Singh, S. B., & Srivastava, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85041-4.00016-0 · Cited by 1
Delivery of Vaccines via the Nasal Route
Amponsah, S. K., & Amoafo, E. B. (2023) · Springer eBooks · doi:10.1007/978-3-031-23112-4_8 · Cited by 1
Significance of Ziprasidone Nanoparticles in Psychotic Disorders
Patil, M., Patil, J., Patil, D., Patel, K., & Tatiya, A. (2023) · doi:10.3390/iocn2023-14503 · Cited by 1
Development of a Nose-to-Brain system utilizing neural circuits based on a new concept
Yamashita, C. (2023) · Drug Delivery System · doi:10.2745/dds.38.134 · Cited by 1
Potential Therapeutics from Ayurveda, Siddha, and Homeopathic Medical System for Alzheimer’s Disease
Chandrani, S., & Thenmozhi, A. J. (2023) · Nutritional neurosciences · doi:10.1007/978-981-99-0677-2_12 · Cited by 3
Intranasale Schmerzmittel in der Notfallmedizin – was ist die Evidenz? Teil 1 Fentanyl
Ahne, G., Dormann, H., & Neubert, A. C. (2024) · Notarzt · doi:10.1055/a-2230-5541 · Cited by 1
Patil, S., Karpe, S. T., Bhagwat, A., Mali, S., Vasugade, P., & Barbole, R. (2024) · International Journal of Research Publication and Reviews · doi:10.55248/gengpi.5.0524.1256 · Cited by 1
Intranasal Delivery of Drugs to the Central Nervous System
Crowe, T. P., & Hsu, W. H. (2024) · AAPS introductions in the pharmaceutical sciences · doi:10.1007/978-3-031-62604-3_6 · Cited by 2
Intranasal therapies for neonatal hypoxic-ischemic encephalopathy
Cavanagh, A. S., Kuter, N., Sollinger, B. I., Aziz, K. B., Turnbill, V., Martin, L. J., & Northington, F. J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01036 · Cited by 2
Preparation and evaluation of a thermosensitive hydrogel for the nasal delivery of insulin
Nazar, H. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Cytochrome P450-mediated drug metabolizing activity in the nasal mucosa
Dhamankar, V. (2013) · doi:10.17077/etd.9ozi7j61 · Cited by 2
Boisa, N. (2013) · Northumbria Research Link (Northumbria University) · Cited by 2
Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines
Rautiola, D. (2019) · University of Minnesota Digital Conservancy (University of Minnesota) · Cited by 1
studies, O. T. R. N. C. E. S. C. I. C., device, A. S. P. A. E. I. C. S. U. T. R. P. R. C. D. P. I. (. A. W. A. D. D., sensors, I. I. P. T. U. E. A. V. O. D. T. S. D. T. B. T. C. B. O. B. I. T. T. O. D. W. T. C. S. B. E. T. C. W. A. V. O. C. O. (., data, W. A. A. T. I. S. C. P. B. W. O. L. T., capsule, I. F. T. P. T., profile, I. F., instrumentation, O. O. I. T. A. C. O. S. C. E. T. E. A. T. I., studies, W. T. D. I. D. F. L. I. C., usage, R. A. S. I. I. T. L. O. U. D. C. I. I. A. C. T. T. Q. D. C. P. I. C. O. A., studies, P. I. W. D. O. C. B. D. F. D. E., et al. (2020) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2020.ab01.abstracts · Cited by 1
Luciani-Giacobbe, L. C., Sanchez, M. F., & Olivera, M. E. (2021) · Springer eBooks · doi:10.1007/978-3-030-51519-5_102-1 · Cited by 1
Pösel, C., Wagner, D. C., Scheibe, J., Kranz, A., Bothe, V., Lange, F., Schäbitz, W. R., Minnerup, J., & Boltze, J. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16639008 · Cited by 1
Q-Griffithsin interactions and utility for the prevention and treatment of Mucosal infections.
Nabeta, H. W. (2021) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3766 · Cited by 1
Les voies transmuqueuses, des alternatives intéressantes
Bochot, A., Chambin, O., & Pillon, F. (2011) · Actualités Pharmaceutiques · doi:10.1016/s0515-3700(11)71017-5
Fulton, H. G. (2011) · Library and Archives Canada (Government of Canada)
Pheroid™ Vesicles and Microsponges for Nasal Delivery of Biopharmaceuticals
Plessis, D., & Kotzé, A. F. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9524-6_14
Evaluation of Intranasal Gene Delivery by a Lipoplex Formulation
Waszczak, B. L. (2010)
Intranasal delivery of pGDNF nanoparticles for Parkinson's disease
Harmon, B. T. (2013) · Digital Repository Service (Northeastern University) · doi:10.17760/d20003327
Nanostructures for Nasal Vaccine Delivery
Slütter, B., & Jiskoot, W. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849735292-00156
Бурлака, Б. С. (2015) · Фармацевтичний часопис · doi:10.11603/2312-0967.2015.1.3765
Midazolam intranasal pour arrêter les convulsions en contexte extra-hospitalier
Zelcer, M., & Goldman, R. D. (2016) · Europe PMC (PubMed Central)
Technologies for controlling ultrasound targeted drug delivery in brain using animal models
Dias, A. C. P. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The Needle-Less Treatment of Pain and Anxiety in the Pediatric Patient
Gardner, A. R., & Myers, K. (2017) · Current Emergency and Hospital Medicine Reports · doi:10.1007/s40138-017-0141-6
Prentice, R. N. (2020) · Otago University Research Archive (University of Otago)
Thakkar, J. H., & Prajapati, S. T. (2020) · Journal of Emerging Technologies and Innovative Research
Indices of oxidative stress under intranasal administration of deicing reagent solutions in rats
Lv, K., Vodianova, M. A., Knyazeva, T. D., Koganova, Z. I., Makovetskaya, A. K., Николаевна, С. О., Alekseeva, A. V., Ushakova, O. V., Mamonov, R. A., & Malyugina, A. V. (2021) · Hygiene and Sanitation · doi:10.47470/0016-9900-2020-99-12-1446-1453
TARGETABLE MULTI-DRUG NANOPARTICLES FOR TREATMENT OF GLIOBLASTOMA WITH NEUROIMAGING ASSESSMENT
Smiley, S. B. (2020) · Purdue e-Pubs (Purdue University System) · doi:10.25394/pgs.12221780.v1
Development of Polymer-based Sol-Gel Therapeutics for Parkinson's Disease
Kafritsas, J. G. (2021) · Griffith Research Online · doi:10.25904/1912/4289
Development of Novel Polysaccharides-Based Cryogels for Drug Delivery Applications
Gholizadeh, H. (2021) · Tuwhera (Auckland University of Technology)
(2022) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2022/11.1.2027
Metadata
- Authors
- Pires, A., Fortuna, A., Alves, G., & Falcão, A.
- Affiliations
- University of Coimbra (PT)
- University of Beira Interior (PT)
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2009-10-12
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W2106536537
- Cited by
- 641
- References
- 175
- Citations by year
- 2026: 31 · 2025: 49 · 2024: 44 · 2023: 45 · 2022: 67 · 2021: 65 · 2020: 48 · 2019: 41 · 2018: 35 · 2017: 42 · 2016: 35 · 2015: 29 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-sa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/45145/2008)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, nasal mucosa, transmucosal drug absorption, brain drug delivery, topical drug delivery, systemic drug delivery
- MeSH terms
- Absorption, Administration, Intranasal, Animals, Biological Availability, Humans, Nasal Cavity, Nasal Mucosa, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.